TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30472902

Group type: EXPERIMENTAL
Intervention: CLM‐L tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate release CLM tablets
Number of subjects: 0
Study: 28109266

Group type: EXPERIMENTAL
Intervention: Team-based care (TBC) intervention conducted by an interprofessional team (nurse, community pharmacist, physician) with sessions every 6 weeks for 6 months.
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care (UC) without sessions with a nurse and a pharmacist.
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Team-based care (TBC) intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 110
Study: 26516910

Group type: EXPERIMENTAL
Intervention: 360 microgram menaquinone-7 (MK-7) supplementation for 24 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23786783

Group type: EXPERIMENTAL
Intervention: Interferon beta 44 μg subcutaneously 3 times weekly
Number of subjects: 19

Group type: COMPARATOR
Intervention: Methotrexate 20 mg subcutaneously once weekly
Number of subjects: 19
Study: 22030782

Group type: EXPERIMENTAL
Intervention: Enteral immunonutrition group (n=53)
Number of subjects: 106
Study: 20067113

Group type: EXPERIMENTAL
Intervention: Celecoxib (0.2 g, qd for 7 days before operation)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no medication before resection)
Number of subjects: 36
Study: 17182193

Group type: EXPERIMENTAL
Intervention: One hour additional sleep per night at baseline
Number of subjects: 500

Group type: COMPARATOR
Intervention: Smoking status at follow-up
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Number of cigarettes per day
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Self-assessment of smoking behaviour in 5 years
Number of subjects: 500
Study: 14747361

Group type: EXPERIMENTAL
Intervention: School Intervention Program (SIP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Routine Services (RS)
Number of subjects: 24
Study: 10376168

Group type: EXPERIMENTAL
Intervention: Diclofenac-potassium 50 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Diclofenac-potassium 100 mg
Number of subjects: 156

Group type: COMPARATOR
Intervention: Sumatriptan 100 mg
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Diclofenac-potassium
Number of subjects: 156
Study: 9017176

Group type: EXPERIMENTAL
Intervention: Midazolam (0.2mg/Kg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Hydroxyzine
Number of subjects: 29
Study: 1736759

Group type: EXPERIMENTAL
Intervention: Modified Medical Research Council (MRC) scale
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Oxygen cost diagram (OCD)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Baseline dyspnea index (BDI)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Maximal inspiratory (PImax) and expiratory (PEmax) mouth pressures
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Lung function measures (FVC and FEV1)
Number of subjects: 86
Study: 6474360

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (continuous infusion after premedication)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no prophylaxis)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (for high-risk patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No prophylaxis (for low-risk patients)
Number of subjects: 40
Study: 30017164

Group type: EXPERIMENTAL
Intervention: 0.5% sodium hypochlorite solution
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: water (placebo)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5% sodium bicarbonate solution
Number of subjects: 40
Study: 29732731

Group type: EXPERIMENTAL
Intervention: SAR100842
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 27168135

Group type: EXPERIMENTAL
Intervention: Exercise (30 min moderate-intensity stationary bicycle exercise)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 14
Study: 24178185

Group type: EXPERIMENTAL
Intervention: Immunomodulating enteral nutrition (IMEN)
Number of subjects: 776

Group type: COMPARATOR
Intervention: Standard enteral nutrition (SEN)
Number of subjects: 776

Group type: COMPARATOR
Intervention: Standard parenteral nutrition (SPN)
Number of subjects: 776

Group type: COMPARATOR
Intervention: Immunomodulating parenteral nutrition (IMPN)
Number of subjects: 776
Study: 23740043

Group type: EXPERIMENTAL
Intervention: 20% flow decrease
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 20% flow decrease with phenylephrine to restore baseline pressure
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Increased flow with baseline pressure
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 20% pressure decrease with sodium nitroprusside (SNP) under baseline flow
Number of subjects: 34
Study: 20803859

Group type: EXPERIMENTAL
Intervention: Anterior approach sciatic nerve block
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lateral approach sciatic nerve block
Number of subjects: 120

Group type: COMPARATOR
Intervention: Posterior parasacral approach sciatic nerve block
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Continuous nerve block (all approaches)
Number of subjects: 120
Study: 18959455

Group type: EXPERIMENTAL
Intervention: Live music therapy sessions (pre and postoperative)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 27
Study: 15725984

Group type: EXPERIMENTAL
Intervention: Handout survey
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mailed survey
Number of subjects: 0
Study: 12840089

Group type: EXPERIMENTAL
Intervention: Nebulized epinephrine (1 percent, 4 ml doses)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo (normal saline, 4 ml doses)
Number of subjects: 194
Study: 11197923

Group type: EXPERIMENTAL
Intervention: Psychoeducational family intervention plus individual psychosocial treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Individual psychosocial treatment
Number of subjects: 40
Study: 9275608

Group type: EXPERIMENTAL
Intervention: Rotation advancement method
Number of subjects: 126

Group type: COMPARATOR
Intervention: Triangular flap method
Number of subjects: 126
Study: 2003340

Group type: EXPERIMENTAL
Intervention: Intravenous ofloxacin
Number of subjects: 72

Group type: COMPARATOR
Intervention: Intravenous ceftazidime
Number of subjects: 72
Study: 6396120

Group type: EXPERIMENTAL
Intervention: Bifonazole cream applied once or twice daily
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Clotrimazole applied twice daily
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo applied twice daily
Number of subjects: 275
Study: 30764582

Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa calyces (HSC) extract (250 mL)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 25
Study: 30213037

Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein (CRHP) diet
Number of subjects: 14
Study: 27502808

Group type: COMPARATOR
Intervention: Heat therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Birth ball
Number of subjects: 90
Study: 25089931

Group type: EXPERIMENTAL
Intervention: IL1RN variant rs315952C
Number of subjects: 294
Study: 22420698

Group type: EXPERIMENTAL
Intervention: DATE program (Dating Assertiveness Training Experience)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (no-treatment)
Number of subjects: 139
Study: 20830731

Group type: EXPERIMENTAL
Intervention: GAD-alum (20 μg, two injections)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 18402096

Group type: EXPERIMENTAL
Intervention: Conditioning of the enamel with 38% phosphoric acid (group 1)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Conditioning with phosphoric acid and single-bottle dentin bonding agent (group 2)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Conditioning with a self-etching adhesive (group 3)
Number of subjects: 63
Study: 15850080

Group type: EXPERIMENTAL
Intervention: Baseline
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Faces task
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Sentences task
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Recovery
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 104
Study: 12698306

Group type: EXPERIMENTAL
Intervention: Diosmin 500 mg once daily for 9 days before metronidazole administration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metronidazole 400 mg (two tablets) administered after diosmin pretreatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Metronidazole 400 mg (two tablets) administered alone (no diosmin pretreatment)
Number of subjects: 12
Study: 10481832

Group type: EXPERIMENTAL
Intervention: Clonidine (5 micrograms/kg, p.o.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guanfacine (29 micrograms/kg, p.o.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8354373

Group type: EXPERIMENTAL
Intervention: Contraceptive sponge
Number of subjects: 2833

Group type: EXPERIMENTAL
Intervention: Cervical cap
Number of subjects: 2833

Group type: EXPERIMENTAL
Intervention: Diaphragm
Number of subjects: 2833

Group type: EXPERIMENTAL
Intervention: Contraceptive sponge (post-birth)
Number of subjects: 2833

Group type: EXPERIMENTAL
Intervention: Cervical cap (post-birth)
Number of subjects: 2833

Group type: EXPERIMENTAL
Intervention: Diaphragm (post-birth)
Number of subjects: 2833
Study: 3789514

Group type: EXPERIMENTAL
Intervention: Diaphragmatic fatiguing contractions
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diaphragmatic nonfatiguing contractions
Number of subjects: 6
Study: 28745063

Group type: EXPERIMENTAL
Intervention: Home-based step training using videogame technology
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 27681702

Group type: EXPERIMENTAL
Intervention: Rivastigmine patch (5 cm2 [4.6 mg/24 h], 10 cm2 [9.5 mg/24 h], 15 cm2 [13.3 mg/24 h], and 20 cm2 [17.4 mg/24 h])
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivastigmine capsule (1.5, 3, 4.5, and 6 mg/12 h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model-based estimates of plasma concentrations adjusted for body weight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Renal function (mild/no vs. moderate/severe/end-stage)
Number of subjects: 0
Study: 26560820

Group type: EXPERIMENTAL
Intervention: Combined headgear (CH)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combined headgear + rapid maxillary expansion (CH + RME)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 61
Study: 23445266

Group type: EXPERIMENTAL
Intervention: Intercostal nerve blockade with 20 mL of 0.5% bupivacaine with epinephrine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (20 mL physiologic saline)
Number of subjects: 63
Study: 21465735

Group type: EXPERIMENTAL
Intervention: 15-minute IV infusion of zoledronic acid 4 mg (in 250 mL)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: 30-minute IV infusion of zoledronic acid 4 mg (in 250 mL)
Number of subjects: 176
Study: 20005647

Group type: EXPERIMENTAL
Intervention: Dydrogesterone (40 mg stat followed by 10 mg twice daily)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Conservative management (control group)
Number of subjects: 191
Study: 16979453

Group type: EXPERIMENTAL
Intervention: Patient phone call to assess smoking status, quit challenges, and treatment preferences, and computerized progress note to providers communicating this information
Number of subjects: 1900

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1900
Study: 15343587

Group type: EXPERIMENTAL
Intervention: Insulin (0.05 units/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study: 10942153

Group type: EXPERIMENTAL
Intervention: Dipyridamole, 200 mg p.o., 3‐4 h before surgery
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 10349448

Group type: EXPERIMENTAL
Intervention: Heberbiovac‐HB (0 and 2 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heberbiovac‐HB (0 and 4 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heberbiovac‐HB (0 and 6 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heberbiovac‐HB (0 and 8 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (0, 1 and 6 months)
Number of subjects: 0
Study: 7518932

Group type: EXPERIMENTAL
Intervention: Strontium-89 (200 MBq)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Hemibody radiotherapy
Number of subjects: 284

Group type: COMPARATOR
Intervention: Local radiotherapy
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Strontium-89
Number of subjects: 284
Study: 2498074

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) suspension administered orally after an overnight fast
Number of subjects: 8

Group type: COMPARATOR
Intervention: Carbamazepine (CBZ) suspension administered by nasogastric feeding tube during continuous enteral feeding infusion
Number of subjects: 8
Study: 31868055

Group type: EXPERIMENTAL
Intervention: 2.5% benzoyl peroxide
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 5% benzoyl peroxide
Number of subjects: 89
Study: 30408325

Group type: EXPERIMENTAL
Intervention: Glucoraphanin-rich (GRR) beverage
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sulforaphane-rich (SFR) beverage
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Broccoli beverage consumption
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Rats administered 100 µmol kg-1 SFN
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: TTCA
Number of subjects: 50
Study: 27050109

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (baseline mindfulness scores)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Baseline total FFMQ score
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Baseline body weight
Number of subjects: 140
Study: 25092681

Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban
Number of subjects: 162

Group type: COMPARATOR
Intervention: Intracoronary placebo
Number of subjects: 162
Study: 23201035

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 0
Study: 22000430

Group type: EXPERIMENTAL
Intervention: Nasal synchronized intermittent positive pressure ventilation (NSIPPV)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure ventilation (NCPAP)
Number of subjects: 80
Study: 18454661

Group type: EXPERIMENTAL
Intervention: Locally delivered doxycycline gel at baseline and 1 and 2 years as an adjunct to mechanical debridement
Number of subjects: 128

Group type: COMPARATOR
Intervention: Mechanical debridement only
Number of subjects: 128
Study: 16511917

Group type: EXPERIMENTAL
Intervention: Combination of cyclosporine (CSA) and leflunomide (LEF)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Cyclosporine (CSA)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Leflunomide (LEF)
Number of subjects: 106
Study: 14535175

Group type: EXPERIMENTAL
Intervention: Softening and lubricating the joints, and calming the endogenous wind
Number of subjects: 60

Group type: COMPARATOR
Intervention: Zheng Qing Feng Tong Ning Tablets
Number of subjects: 60
Study: 11136411

Group type: EXPERIMENTAL
Intervention: Nursing intervention program designed to enhance hope
Number of subjects: 115

Group type: COMPARATOR
Intervention: Attention control group (informational)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (usual treatment)
Number of subjects: 115
Study: 8936563

Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole orally once daily for 10 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo orally once daily for 10 days
Number of subjects: 10
Study: 8464611

Group type: EXPERIMENTAL
Intervention: Mucin-containing lozenge
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 42
Study: 3456972

Group type: EXPERIMENTAL
Intervention: Indomethacin (2 X 50 mg daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carprofen (2 X 150 mg daily)
Number of subjects: 8
Study: 29063389

Group type: EXPERIMENTAL
Intervention: Brief psychosocial intervention training for health professionals
Number of subjects: 20
Study: 27793949

Group type: EXPERIMENTAL
Intervention: Sorafenib plus percutaneous radiofrequency ablation (RFA) of both HCC and PVTT
Number of subjects: 99

Group type: COMPARATOR
Intervention: Sorafenib alone
Number of subjects: 99
Study: 23482473

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg once daily for 6 weeks
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily for 12 weeks
Number of subjects: 111

Group type: COMPARATOR
Intervention: Atorvastatin versus placebo
Number of subjects: 111
Study: 22322357

Group type: EXPERIMENTAL
Intervention: BGP-15
Number of subjects: 0
Study: 20499249

Group type: EXPERIMENTAL
Intervention: 6 g L‐citrulline‐malate 2 h prior to exercise
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 17
Study: 19230597

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CFX) 500 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBF) 400 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16044790

Group type: EXPERIMENTAL
Intervention: Conventional evaluation methods (cross‐sectional studies, observational studies, comparative studies, randomised controlled trials, and metaanalyses) applied to complementary and alternative medicine
Number of subjects: 0
Study: 11850711

Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Sequential sargramostim and filgrastim
Number of subjects: 156

Group type: COMPARATOR
Intervention: Sargramostim
Number of subjects: 156
Study: 10361400

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reading control
Number of subjects: 20
Study: 9457977

Group type: EXPERIMENTAL
Intervention: Untreated cervicitis (Group C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chorioamnionitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PROM (Premature Rupture of Membranes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treated cervicitis (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls (Group A)
Number of subjects: 0
Study: 1781005

Group type: EXPERIMENTAL
Intervention: Norfloxacin (7 days, twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chloramphenicol (14 days)
Number of subjects: 40
Study: 7450954

Group type: EXPERIMENTAL
Intervention: Outpatient psychotherapy with urine surveillance
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Outpatient psychotherapy without urine surveillance
Number of subjects: 29

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 29
Study: 30040026

Group type: EXPERIMENTAL
Intervention: 30-degrees rightward deviation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 10-degrees rightward deviation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 20-degrees rightward deviation
Number of subjects: 4

Group type: COMPARATOR
Intervention: No deviation
Number of subjects: 4
Study: 29497768

Group type: EXPERIMENTAL
Intervention: all-seeing needle micro-PCNL
Number of subjects: 116

Group type: COMPARATOR
Intervention: FURS
Number of subjects: 116
Study: 27903136

Group type: EXPERIMENTAL
Intervention: Ending Self‐Stigma (ESS) psychoeducational intervention, 9 weeks duration
Number of subjects: 268

Group type: COMPARATOR
Intervention: Minimally enhanced treatment‐as‐usual control condition
Number of subjects: 268
Study: 25697576

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80mg/day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (20mg/day)
Number of subjects: 120
Study: 24579225

Group type: EXPERIMENTAL
Intervention: Intra-arterial occlusive balloons
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional surgery (Control)
Number of subjects: 12
Study: 21299925

Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone sodium succinate intravenously as a single bolus before surgery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no glucocorticoid)
Number of subjects: 42
Study: 19484436

Group type: EXPERIMENTAL
Intervention: BioVue 3 HSM hydrophilic acrylic IOL
Number of subjects: 177

Group type: COMPARATOR
Intervention: Sensar AR40e hydrophobic acrylic IOL
Number of subjects: 177
Study: 16730721

Group type: EXPERIMENTAL
Intervention: Single strand conformation polymorphism and sequence analysis for DAZL gene polymorphism screening
Number of subjects: 422
Study: 15250791

Group type: EXPERIMENTAL
Intervention: Positive self-stereotypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative self-stereotypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental manipulation of group performance expectation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive in-group stereotypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative stereotypes
Number of subjects: 0
Study: 11389862

Group type: EXPERIMENTAL
Intervention: Yoghurt (125 g twice daily for 8 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (casein‐free soybean ice cream, 125 g twice daily for 8 weeks)
Number of subjects: 42
Study: 9269005

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 0
Study: 8344101

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg post evening meal (pem)
Number of subjects: 1677

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg nocte
Number of subjects: 1677

Group type: COMPARATOR
Intervention: Cimetidine 800 mg nocte
Number of subjects: 1677

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg pem
Number of subjects: 1677
Study: 3753754

Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin-D3 (1,25(OH)2D3) therapy (0.25-0.50 microgram/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Discontinuation of 1,25(OH)2D3 treatment in five children
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acute study during 12 HF sessions
Number of subjects: 10